medigraphic.com
SPANISH

Cirugía Cardiaca en México

ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 1

<< Back Next >>

Cir Card Mex 2024; 9 (1)

Optimizing outcomes in high-risk patients with low left ventricle ejection fraction undergoing coronary artery bypass grafting: a case report

De La Cerda-Belmonta GA, Garza-De La Mazab A, Cepeda-Floresc MG, Vázquez-Gonzáleza RM, Morales-Marína CA, Cruz-Ramosd F, Pedroza-Solisa E
Full text How to cite this article

Language: English
References: 22
Page: 30-34
PDF size: 223.55 Kb.


Key words:

Coronary artery bypass grafting, Left ventricle ejection fraction, low, on-pump beating heart surgery.

ABSTRACT

Managing patients with coronary artery disease and low ejection fraction remains a challenge despite medical advancements. Coronary artery bypass grafting has shown benefits for patients with reduced ejection fraction, but it also carries risks, such as post-cardiotomy shock. Pre and intraoperative strategies, like levosimendan preconditioning, on-pump beating- heart technique, comprehensive revascularization, and backup mechanical support, aim to optimize outcomes. Tailored multidisciplinary (Heart-Team) approaches minimize the risks while maximizing outcomes in high-risk patients.


REFERENCES

  1. Awan NI, Jan A, Rehman MU, Ayaz N. The effect of ejection fraction on mortalityin Coronary Artery Bypass Grafting (CABG) patients. Pak J Med Sci. 2020;36(7):1454-1459. doi: 10.12669/pjms.36.7.3266.

  2. Topkara VK, Cheema FH, Kesavaramanujam S, Mercando ML, Cheema AF,Namerow PB, Argenziano M, Naka Y, Oz MC, Esrig BC. Coronary artery bypassgrafting in patients with low ejection fraction. Circulation. 2005;112(9 Suppl):I344-50. doi: 10.1161/CIRCULATIONAHA.104.526277.

  3. Dalén M, Lund LH, Ivert T, Holzmann MJ, Sartipy U. Survival After CoronaryArtery Bypass Grafting in Patients with Preoperative Heart Failure and Preservedvs Reduced Ejection Fraction. JAMA Cardiol. 2016;1(5):530-8. doi: 10.1001/jamacardio.2016.1465.

  4. Veterans Administration Coronary Artery Bypass Surgery Cooperative StudyGroup. Eleven-year survival in the Veterans Administration randomized trial ofcoronary bypass surgery for stable angina. N Engl J Med. 1984;311(21):1333-9.doi: 10.1056/NEJM198411223112102.

  5. Petrie MC, Jhund PS, She L, et al; STICH Trial Investigators. Ten-Year OutcomesAfter Coronary Artery Bypass Grafting According to Age in Patients withHeart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the ExtendedFollow-Up of the STICH Trial (Surgical Treatment for Ischemic HeartFailure). Circulation. 2016;134(18):1314-1324. doi: 10.1161/CIRCULATIONAHA.116.024800.

  6. Jiménez-Rivera JJ, Álvarez-Castillo A, Ferrer-Rodríguez J, et al. Preconditioningwith levosimendan reduces postoperative low cardiac output in moderate-severesystolic dysfunction patients who will undergo elective coronary artery bypassgraft surgery: a cost-effective strategy. J Cardiothorac Surg. 2020;15(1):108. doi:10.1186/s13019-020-01140-z.

  7. Tong MZY, Weiss AJ, Bakaeen F, Soltesz EG. CABG in Failing Hearts: A Howto-Guide to Using Modern Mechanical Support as Backup. Innovations (Phila).2021;16(3):227-230. doi: 10.1177/15569845211016455.

  8. Ali JM, Abu-Omar Y. Mechanical support for high-risk coronary artery bypassgrafting. Indian J Thorac Cardiovasc Surg. 2018;34(Suppl 3):287-296. doi:10.1007/s12055-018-0740-1.

  9. Erkut B, Dag O, Kaygin MA, et al. On-pump beating-heart versus conventionalcoronary artery bypass grafting for revascularization in patients with severe leftventricular dysfunction: early outcomes. Can J Surg. 2013;56(6):398-404. doi:

  10. 10.1503/cjs.018412.10. Samuels L, Samuels M. Pump-Assisted Beating-Heart Coronary Artery BypassGrafting: The Pursuit of Perfection. J Clin Exp Cardiolog 8: 540. doi:10.4172/2155-9880.1000540.

  11. Dominici C, Salsano A, Nenna A, et al. On-pump beating-heart coronary arterybypass grafting in high-risk patients: A systematic review and meta-analysis. JCard Surg. 2020;35(8):1958-1978. doi: 10.1111/jocs.14780.

  12. Xia L, Ji Q, Song K, et al. Early clinical outcomes of on-pump beating-heart versusoff-pump technique for surgical revascularization in patients with severe leftventricular dysfunction: the experience of a single center. J Cardiothorac Surg.2017;12(1):11. doi: 10.1186/s13019-017-0572-x.

  13. Samuels L, Stella A, Raws S, Arce A. Pump-Assisted Direct Coronary Artery Bypass(PAD- CAB) in Patients with Low Ejection Fraction: Potential Advantages.Cardiovascular Surgery International. 2022;3: Article1018. Available at: https://www.medtextpublications.com/open-access/pump-assisted-direct-coronary-artery-bypass-padcab-in-patients-with-low-1091.pdf. Last access: July 21, 2023.

  14. Perrault LP, Menasché P, Peynet J, et al. On-pump, beating-heart coronary arteryoperations in high-risk patients: an acceptable trade-off? Ann Thorac Surg.1997;64(5):1368-73. doi: 10.1016/S0003-4975(97)00842-4.

  15. Hwang B, Williams ML, Tian DH, Yan TD, Misfeld M. Coronary artery bypasssurgery for acute coronary syndrome: A network meta-analysis of on-pump cardioplegicarrest, off-pump, and on-pump beating heart strategies. J Card Surg.2022;37(12):5290-5299. doi: 10.1111/jocs.17149.

  16. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonanceimaging to identify reversible myocardial dysfunction. N Engl J Med.2000;343(20):1445-53. doi: 10.1056/NEJM200011163432003.

  17. Molchanova-Cook O, Chen W. Role of FDG-PET in Evaluation of MyocardialViability. PET Clin. 2011;6(4):383-91. doi: 10.1016/j.cpet.2011.08.003.

  18. Cholley B, Caruba T, Grosjean S, et al. Effect of Levosimendan on Low CardiacOutput Syndrome in Patients with Low Ejection Fraction Undergoing CoronaryArtery Bypass Grafting with Cardiopulmonary Bypass: The LICORN RandomizedClinical Trial. JAMA. 2017;318(6):548-556. doi: 10.1001/jama.2017.9973.

  19. Mehta RH, Leimberger JD, van Diepen S, et al; LEVO-CTS Investigators. Levosimendanin Patients with Left Ventricular Dysfunction Undergoing CardiacSurgery. N Engl J Med. 2017;376(21):2032-2042. doi: 10.1056/NEJMoa1616218.

  20. Landoni G, Lomivorotov VV, Alvaro G, et al; CHEETAH Study Group. Levosimendanfor Hemodynamic Support after Cardiac Surgery. N Engl J Med.2017;376(21):2021-2031. doi: 10.1056/NEJMoa1616325.

  21. Ramzy D, Soltesz E, Anderson M. New Surgical Circulatory Support System Outcomes.ASAIO J. 2020;66(7):746-752. doi: 10.1097/MAT.0000000000001194.

  22. Kawashima D, Gojo S, Nishimura T, et al. Left ventricular mechanical supportwith Impella provides more ventricular unloading in heart failure than extracorporealmembrane oxygenation. ASAIO J. 2011;57(3):169-76. doi: 10.1097/MAT.0b013e31820e121c.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Card Mex. 2024;9